Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma. | J Oncol | 2023 | 36644235 | PubTator, text mining | PubMed |
| BTK inhibitor combined with anti-PD-1 monoclonal antibody for the treatment of CD20-negative primary central nervous system lymphoma: A case report. | Oncol Lett | 2023 | 36644138 | PubTator, text mining | PubMed |
| Primary Cardiac Lymphoma Presenting with Thrombocytopenia, Right Heart Failure, and Cardiogenic Shock. | Case Rep Hematol | 2023 | 36643956 | PubTator, text mining | PubMed |
| Development of inferiority-compensation scale among high school students. | BMC Med Educ | 2023 | 36635748 | PubTator, text mining | PubMed |
| Exosomal proteomics identifies RAB13 as a potential regulator of metastasis for HCC. | Hepatol Commun | 2023 | 36633475 | PubTator, text mining | PubMed |
| Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial. | Blood | 2023 | 36626583 | PubTator, text mining | PubMed |
| Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. | Nat Med | 2023 | 36624313 | PubTator, text mining | PubMed |
| Integrated Single-Cell (Phospho-)Protein and RNA Detection Uncovers Phenotypic Characteristics and Active Signal Transduction of Human Antibody-Secreting Cells. | Mol Cell Proteomics | 2023 | 36623694 | PubTator, text mining | PubMed |
| A multi-view latent variable model reveals cellular heterogeneity in complex tissues for paired multimodal single-cell data. | Bioinformatics | 2023 | 36622018 | PubTator, text mining | PubMed |
| Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma. | Cells | 2023 | 36611989 | PubTator, text mining | PubMed |
| A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia. | Blood Adv | 2023 | 36607839 | PubTator, text mining | PubMed |
| Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. | Am J Hematol | 2023 | 36606708 | PubTator, text mining | PubMed |
| Molecular profiling of EBV associated diffuse large B-cell lymphoma. | Leukemia | 2023 | 36604606 | PubTator, text mining | PubMed |
| Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report. | Cureus | 2023 | 36601362 | PubTator, text mining | PubMed |
| Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis. | Neurol Sci | 2023 | 36599976 | PubTator, text mining | PubMed |
| Signaling pathways in brain tumors and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36596785 | PubTator, text mining | PubMed |
| Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination. | Adv Sci (Weinh) | 2023 | 36594618 | PubTator, text mining | PubMed |
| Engineering of a plant-produced virus-like particle to improve the display of the Plasmodium falciparum Pfs25 antigen and transmission-blocking activity of the vaccine candidate. | Vaccine | 2023 | 36585278 | PubTator, text mining | PubMed |
| Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas. | Cancer Cell | 2023 | 36584673 | PubTator, text mining | PubMed |
| An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2. | Cell Host Microbe | 2023 | 36563691 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=43